Publication: VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression.
dc.contributor.author | Delgado-Bellido, Daniel | |
dc.contributor.author | Fernández-Cortés, Mónica | |
dc.contributor.author | Rodríguez, María Isabel | |
dc.contributor.author | Serrano-Sáenz, Santiago | |
dc.contributor.author | Carracedo, Arkaitz | |
dc.contributor.author | Garcia-Diaz, Angel | |
dc.contributor.author | Oliver, F Javier | |
dc.date.accessioned | 2023-01-25T10:09:28Z | |
dc.date.available | 2023-01-25T10:09:28Z | |
dc.date.issued | 2018-05-21 | |
dc.description.abstract | Aberrant extra-vascular expression of VE-cadherin (VEC) has been observed in metastasis associated with vasculogenic mimicry (VM); however, the ultimate reason why non-endothelial VEC favors the acquisition of this phenotype is not established. In this study, we show that human malignant melanoma cells have a constitutively high expression of phoshoVEC (pVEC) at Y658; pVEC is a target of focal adhesion kinase (FAK) and forms a complex with p120-catenin and the transcriptional repressor kaiso in the nucleus. FAK inhibition enabled kaiso to suppress the expression of its target genes and enhanced kaiso recruitment to KBS-containing promoters. Finally we have found that ablation of kaiso-repressed genes WNT11 and CCDN1 abolished VM. Thus, identification of pVEC as a component of the kaiso transcriptional complex establishes a molecular paradigm that links FAK-dependent phosphorylation of VEC as a major mechanism by which ectopical VEC expression exerts its function in VM. | |
dc.identifier.doi | 10.1038/s41418-018-0125-4 | |
dc.identifier.essn | 1476-5403 | |
dc.identifier.pmc | PMC6329820 | |
dc.identifier.pmid | 29786069 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329820/pdf | |
dc.identifier.unpaywallURL | https://www.nature.com/articles/s41418-018-0125-4.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/12494 | |
dc.issue.number | 2 | |
dc.journal.title | Cell death and differentiation | |
dc.journal.titleabbreviation | Cell Death Differ | |
dc.language.iso | en | |
dc.organization | Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica-GENYO | |
dc.page.number | 348-361 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.rights.accessRights | open access | |
dc.subject.mesh | Antigens, CD | |
dc.subject.mesh | Cadherins | |
dc.subject.mesh | Catenins | |
dc.subject.mesh | Cell Line, Tumor | |
dc.subject.mesh | Cyclin D1 | |
dc.subject.mesh | Focal Adhesion Kinase 1 | |
dc.subject.mesh | Gene Expression | |
dc.subject.mesh | Gene Knockout Techniques | |
dc.subject.mesh | HEK293 Cells | |
dc.subject.mesh | Human Umbilical Vein Endothelial Cells | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Melanoma | |
dc.subject.mesh | Neovascularization, Pathologic | |
dc.subject.mesh | Phosphorylation | |
dc.subject.mesh | Skin Neoplasms | |
dc.subject.mesh | Transcription Factors | |
dc.subject.mesh | Transduction, Genetic | |
dc.subject.mesh | Wnt Proteins | |
dc.subject.mesh | Delta Catenin | |
dc.title | VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 26 | |
dspace.entity.type | Publication |